110268 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
GENE THERAPY
#2NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF
#3FUSOSOME COMPOSITIONS AND USES THEREOF
#4VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#5METHODS AND COMPOSITIONS FOR BAT IPSC PREPARATION AND USE
#6COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY
#7LIPID PARTICLES CONTAINING A TRUNCATED BABOON ENDOGENOUS RETROVIRUS (BaEV) ENVELOPE GLYCOPROTEIN AND RELATED METHODS AND USES
#8LTR TRANSPOSON COMPOSITIONS AND METHODS
#9Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
#10Vaccine for use in the prophylaxis and/or treatment of a disease
#11PNMA2-BASED CAPSIDS AND USES THEREOF
#12A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#13TARGETED INTEGRATION IN MAMMALIAN SEQUENCES ENHANCING GENE EXPRESSION
#14COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#15Vaccine for use in the prophylaxis and/or treatment of a disease
#16Vaccine for use in the prophylaxis and/or treatment of a disease
#17METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES TO EXPRESS POLYPEPTIDES COMPRISING THE INTRACELLULAR DOMAIN OF CD79A AND CD79B
#18UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING UROTHELIAL CELLS
#19VIRUS-LIKE PARTICLE
#20ARTIFICIAL RIBOSOMES FOR FULLY PROGRAMMABLE SYNTHESIS OF NONRIBOSOMAL PEPTIDES
#21FUSOSOME COMPOSITIONS AND USES THEREOF
#22Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
#23NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS
#24Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
#25Infectious disease vaccine using non-infectious paramyxovirus particle
#26Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
#27HUMAN ENDOGENOUS RETROVIRAL PROTEIN
#28Artificial ribosomes for fully programmable synthesis of nonribosomal peptides
#29Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
#30Stable pseudotyped lentiviral particles and uses thereof
#31Immunostimulating peptides
#32Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
#33USE OF HUMAN DERIVED IMMUNOSUPPRESSIVE PROTEINS AND PEPTIDES AS MEDICAMENTS
#34Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
#35Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
#36Dimeric reverse transcriptase
#37Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides
#38Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
#39Baculovirus-based vaccines
#40Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#41ENDOGENETIC RETROVIRAL SEQUENCES, ASSOCIATED WITH AUTOIMMUNE DISEASES OR WITH PREGNANCY DISORDERS
#42Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof
#43IMMUNOSUPPRESSIVE PEPTIDE
#44NOVEL HUMAN ENDOGENOUS RETROVIRAL ERV3 VARIANT AND USES THEREOF IN THE DIAGNOSING OVARIAN CANCER
#45Fusion Protein Delivery System and Uses Thereof
#46Method for diagnosing and/or treating tumor
#47COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#48ENDOGENOUS RETROVIRUSES UP-REGULATED IN PROSTATE CANCER
#49Trimerizing polypeptides
#50Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use
#51Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region
#52Baculovirus-Based Vaccines
#53Endogenous retroviruses up-regulated in prostate cancer
#54RECOMBINANT PROTEINS AND VIRUS LIKE PARTICLES COMPRISING L AND S POLYPEPTIDES OF AVIAN HEPADNAVIRIDAE AND METHODS, NUCLEIC ACID CONSTRUCTS, VECTORS AND HOST CELLS FOR PRODUCING SAME
#55Methods of diagnosing renal cell carcinoma
#56Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
#57Chimeric influenza virus-like particles
#58NUCLEIC SEQUENCE AND DEDUCED PROTEIN SEQUENCE FAMILY WITH HUMAN ENDOGENOUS RETROVIRAL MOTIFS, AND THEIR USES
#59Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses
#60Polynucleotide fragments of an infectious human endogenous retrovirus
#61MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE
#62Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor
#63Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
#64Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof
#65COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#66COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#67Fusion protein delivery system and uses thereof
#68Trimerizing polypeptides
#69COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#70COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#71COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#72COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#73COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#74COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#75COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#76COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#77Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#78Multiple Sclerosis-related superantigen
#79Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
#80Lupus antibodies for passive immunotherapy of HIV/AIDS
#81Synthetic mammalian retrotransposon gene
#82Endogenous retrovirus polypeptides linked to oncogenic transformation
#83Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
#84Compositions and methods for the therapy and diagnosis of breast cancer
#85Elimination of endogenous porcine retrovirus
#86Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses
#87Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
#88Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
#89Feline bronchioloalveolar lung carcinoma xenograft and cell line
#90Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
#91PERV screening method and use thereof
#92Fusion protein delivery system and uses thereof